Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: EMBO Molecular Medicine ; 6 (2014), 2. - S. 226-38-238. - ISSN 1757-4676. - eISSN 1757-4684
- Schlagwort
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Ereignis
-
Veröffentlichung
- (wo)
-
Konstanz
- (wer)
-
Bibliothek der Universität Konstanz
- (wann)
-
2014
- Beteiligte Personen und Organisationen
-
Basler, Michael
Mundt, Sarah
Muchamuel, Tony
Moll, Carlo
Jiang, Jing
Groettrup, Marcus
Kirk, Christopher J.
- URN
-
urn:nbn:de:bsz:352-283233
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:47 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Basler, Michael
- Mundt, Sarah
- Muchamuel, Tony
- Moll, Carlo
- Jiang, Jing
- Groettrup, Marcus
- Kirk, Christopher J.
- Bibliothek der Universität Konstanz
Entstanden
- 2014
Ähnliche Objekte (12)
Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
The ubiquitin-like modifier FAT10 interacts with HDAC6 and localizes to aggresomes under proteasome inhibition
Inhibition and deficiency of the immunoproteasome subunit LMP7 suppress the development and progression of colorectal carcinoma in mice
PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines
Editorial Overview: Molecular immunology : targeting the immune system
Subunit specific inhibitors of proteasomes and their potential for immunomodulation
The unique functions of tissue-specific proteasomes
No essential role for tripeptidyl peptidase II for the processing of LCMV-derived T cell epitopes
Advances in Prostate Cancer Immunotherapies
The ubiquitin-like modifier FAT10 in cancer development
On the Role of the Immunoproteasome in Protein Homeostasis
Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
The ubiquitin-like modifier FAT10 interacts with HDAC6 and localizes to aggresomes under proteasome inhibition
Inhibition and deficiency of the immunoproteasome subunit LMP7 suppress the development and progression of colorectal carcinoma in mice
PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines
Editorial Overview: Molecular immunology : targeting the immune system
Subunit specific inhibitors of proteasomes and their potential for immunomodulation
The unique functions of tissue-specific proteasomes
No essential role for tripeptidyl peptidase II for the processing of LCMV-derived T cell epitopes
Advances in Prostate Cancer Immunotherapies
The ubiquitin-like modifier FAT10 in cancer development
On the Role of the Immunoproteasome in Protein Homeostasis
Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
The ubiquitin-like modifier FAT10 interacts with HDAC6 and localizes to aggresomes under proteasome inhibition
Inhibition and deficiency of the immunoproteasome subunit LMP7 suppress the development and progression of colorectal carcinoma in mice
PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines
Editorial Overview: Molecular immunology : targeting the immune system
Subunit specific inhibitors of proteasomes and their potential for immunomodulation
The unique functions of tissue-specific proteasomes
No essential role for tripeptidyl peptidase II for the processing of LCMV-derived T cell epitopes
Advances in Prostate Cancer Immunotherapies
The ubiquitin-like modifier FAT10 in cancer development